This inventor holds 1 USPTO granted patent, plus 1 CIPO patent and 1 EPO patent. Top assignees: Centre Hospitalier Régional Universitaire De Lille, Centre National De La Recherche Scientifique, National Institute of Health and Medical Research. Active years: 2017.
Company Filing History:
1 out of 26 
1 out of 5,383 
1 out of 1,853 
Years Active: 2017
Introduction
Mohamed El Nady is an accomplished inventor located in Wattignies, France. He has made significant contributions to the field of medical research, particularly in addressing inflammatory autoimmune diseases. His innovative work has garnered attention within the scientific community and highlights the importance of targeted therapies.
Latest Patents
El Nady holds a notable patent titled "28 kDa GST proteins from schistosoma for the use thereof in the treatment of inflammatory autoimmune diseases generating a Th1 and/or Th17 response." This patent pertains to a product comprising the 28 kDa glutathione S-transferase protein derived from schistosomes, associated with the treatment of inflammatory autoimmune diseases that elicit a Th1 and/or Th17 type response. His invention encompasses a range of applications including proteins, protein fragments, derived sequences, and homologous sequences aimed at therapeutic use.
Career Highlights
Throughout his career, El Nady has collaborated with prestigious institutions, including the Université du Droit et de la Santé de Lille 2 and the Institut National de la Santé et de la Recherche Médicale (INSERM). His work has significantly contributed to advancements in medical research and therapeutic interventions in autoimmune conditions.
Collaborations
El Nady has had the privilege of working alongside distinguished colleagues such as Monique Capron and Jean-Frederic Colombel. Their collaborative efforts have fostered an environment of innovation and scientific inquiry, essential for the progression of research in autoimmune diseases.
Conclusion
In summary, Mohamed El Nady is a remarkable inventor whose contributions to the field of medicine are profound. His patent on GST proteins from schistosoma represents a significant stride in the treatment of inflammatory autoimmune diseases. Through his collaborations and dedication to research, El Nady continues to inspire advancements in health and innovation.